Albuminuria and CKD: Tackling the silent marker with SGLT2 inhibitors

Mar
20
11:00 AM

Chronic kidney disease (CKD) is often a silent but progressive condition, with albuminuria serving as a key marker of kidney damage and cardiovascular risk. Recent advances in nephrology have highlighted the crucial role of sodium-glucose cotransporter-2 (SGLT2) inhibitors in slowing CKD progression and reducing albuminuria.

Panelists

Dr.Rohit Khandelwal

Consultant Nephrologist at Navjeevan Hospital, Gwalior

Albuminuria and CKD: Tackling the silent marker with SGLT2 inhibitors

Mar
20
11:00 AM

Chronic kidney disease (CKD) is often a silent but progressive condition, with albuminuria serving as a key marker of kidney damage and cardiovascular risk. Recent advances in nephrology have highlighted the crucial role of sodium-glucose cotransporter-2 (SGLT2) inhibitors in slowing CKD progression and reducing albuminuria.

Panelists

Dr.Rohit Khandelwal

Consultant Nephrologist at Navjeevan Hospital, Gwalior

CONNECT WITH US

Archived Videos

loading..

CONNECT WITH US

Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks

Quick Links

Useful Links

Medbytes FAQ
About Us
Medtalks TV
Contact Us
Webinars
Privacy Policy
CMEs
Terms And Conditions
Conferences

Connect With Us